Drug Profile
Research programme: oral malaria vaccine - Cobra Biomanufacturing/US NMRC
Alternative Names: Oral malaria vaccine - Cobra Biomanufacturing/US NavyLatest Information Update: 12 Oct 2010
Price :
$50
*
At a glance
- Originator Naval Medical Research Center
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Malaria
Most Recent Events
- 22 Feb 2010 Discontinued - Preclinical for Malaria in USA (PO)
- 06 Mar 2008 Preclinical development is ongoing
- 26 Oct 2006 Preclinical trials in Malaria in USA (PO)